WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D4 receptor activation
WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D4 receptor activation
复制标题
DOI:
10.1097/fbp.0b013e3283242f1a
复制
发表时间:
2009-02-01
影响因子:
1.6
通讯作者:
Nichols, David E.
中科院分区:
文献类型:
--
作者:
Marona-Lewicka, Danuta;Nichols, David E.
In-vitro studies have shown that WAY 100635 is not only a potent 5-HT1A antagonist, but also has high affinity and efficacy at the dopamine D-4 receptor. Nevertheless, the behavioral effects of this compound have not been investigated. This study sought to characterize the discriminative stimulus effects produced by WAY 100635. Male Sprague-Dawley rats were trained in a two-lever, fixed ratio 50, food-reinforced task with WAY 100635 (10 mu mol/kg) as a discriminative stimulus. Substitution tests with different doses of WAY 100635 and (-)-pindolol, and combination tests with two 5-HT1A agonists, 8-OH-DPAT and LY 293284; and two dopamine D4 antagonists, sonepiprazole and A-381393, were performed. Rats trained with a low dose (0.74 mu mol/kg) of WAY 100635 could not learn the discrimination task after more than 3 months of sessions. Rats trained to discriminate 10 mu mol/kg of WAY 100635 from saline achieved the criterion of accuracy after approximately 35 training sessions. WAY 100635 (2.5-10 mu mol/kg) produced a dose-dependent increase in WAY 100635-appropriate responding, with a mean effective dose of 3.44 mu mol/kg, whereas saline or pindolol (5-25 mu mol/kg) administration resulted in 0% drug lever responding. Pretreatment with the 5-HT1A agonists 8-OH-DPAT or LY 293284 did not modify the WAY 100635 curve, but pretreatment with the selective dopamine D-4 antagonists sonepiprazole or A-381393 completely blocked the cue. These results indicate that the discriminative stimulus effect produced by WAY 100635 is mediated by activation of dopamine D-4 receptors. Behavioural Pharmacology 20:114-118 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.